Duke SciReg Lab Public Comments

Students in the Duke University Science Regulation (SciReg) Lab routinely submit public comments to federal agency requests for comments. SciPol.org has archived those comments here.

The purpose of the SciReg Lab is to teach about the use of emerging science and technology in the courts and regulatory agencies through the drafting and submission of amicus briefs and comments to federal rulemakings

SciPol.org links to the comments merely to provide examples of public comments, particularly those that are well-researched and developed. SciPol.org does not endorse nor oppose these comments nor any of the statements made within them.

Public comments need not be as detailed as the ones presented here; indeed, in most cases, federal agencies are required to consider any "relevant matter presented" (5 U.S.C. 553(c)) to them within public comments (Administrative Procecedure Act, Public Law 79-404, 5 U.S.C. 551 et seq.

To learn more about submitting effective public comments, view these resources from Regulations.gov ("Tips for Submitting Effective Comments"), the Department of Health and Human Services ("How to Participate in the Rulemaking Process"), and the Environmental Protection Agency ("Tips for Effective Comments").

2019 SciReg Lab Comments

  • February 13 – Comment on FDA Proposed Rule: Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Investigations, 83 FR 57378
  • February 15 – Comment on the Social Security Administration’s Consideration of Pain in the Disability Determination Process, 83 FR 64493
  • February 25 – Comment on the Department of Transportation’s Request for Comments: Vehicle-to-Everything (V2X) Communications, 83 FR 66338

2018 SciReg Lab Comments

  • March 19Comment on FDA Draft Guidance for Industry: Drug Products, Including Biological Products, that Contain Nanomaterials, 82 FR 60019
  • March 20Comment on FDA Draft Guidance for Staff and Industry: Drug Products Labeled as Homeopathic, 82 FR 60403